サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1121078

世界の大容量非経口医薬品 （LVP）市場：考察と予測 (2028年まで)

Global Large Volume Parenteral (LVP) Market Insights and Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 128 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
世界の大容量非経口医薬品 （LVP）市場：考察と予測 (2028年まで)
出版日: 2022年09月01日
発行: QYResearch
ページ情報: 英文 128 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、大容量非経口医薬品 （LVP） (Large Volume Parenteral (LVP)) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 大容量非経口医薬品 （LVP）の製品概要
  • 市場：タイプ別
    • 世界の大容量非経口医薬品 （LVP）の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Soft Bag LVP
    • Plastic Bottle LVP
    • Glass Bottle LVP
  • 市場：アプリケーション別
    • 世界の大容量非経口医薬品 （LVP）の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Basic Infusion
    • Therapeutic Infusion
    • Nutritious Infusion
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の大容量非経口医薬品 （LVP）の販売 推定および予測 2017-2028
  • 世界の大容量非経口医薬品 （LVP）の収益 推定および予測 2017-2028
  • 世界の大容量非経口医薬品 （LVP）の収益：地域別: 2017 VS 2021 VS 2028
  • 世界の大容量非経口医薬品 （LVP）の販売：地域別
    • 世界の大容量非経口医薬品 （LVP）の販売：地域別 (2017-2022)
    • 世界の販売 大容量非経口医薬品 （LVP） ：地域別 (2023-2028)
  • 世界の大容量非経口医薬品 （LVP）の収益：地域別
    • 世界の大容量非経口医薬品 （LVP）の収益：地域別 (2017-2022)
    • 世界の大容量非経口医薬品 （LVP）の収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合：メーカー別

  • 世界の大容量非経口医薬品 （LVP）の販売：メーカー別
    • 世界の大容量非経口医薬品 （LVP）の上位メーカー：販売別 (2017-2022)
    • 世界の大容量非経口医薬品 （LVP）の販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： 大容量非経口医薬品 （LVP）2021
  • 世界の大容量非経口医薬品 （LVP）の収益：メーカー別
    • 世界の大容量非経口医薬品 （LVP）の収益：メーカー別 (2017-2022)
    • 世界の大容量非経口医薬品 （LVP）の収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： 大容量非経口医薬品 （LVP）の収益 2021
  • 世界の大容量非経口医薬品 （LVP）の販売価格：メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界の大容量非経口医薬品 （LVP）の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界の大容量非経口医薬品 （LVP）のメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の大容量非経口医薬品 （LVP）の販売：タイプ別
    • 世界の大容量非経口医薬品 （LVP）の販売実績：タイプ別 (2017-2022)
    • 世界の大容量非経口医薬品 （LVP）の販売予測：タイプ別 (2023-2028)
    • 世界の大容量非経口医薬品 （LVP）の販売市場シェア：タイプ別 (2017-2028)
  • 世界の大容量非経口医薬品 （LVP）の収益：タイプ別
    • 世界の大容量非経口医薬品 （LVP）の収益実績：タイプ別 (2017-2022)
    • 世界の大容量非経口医薬品 （LVP）の収益予測：タイプ別 (2023-2028)
    • 世界の大容量非経口医薬品 （LVP）の収益市場シェア：タイプ別 (2017-2028)
  • 世界の大容量非経口医薬品 （LVP）の価格：タイプ別
    • 世界の大容量非経口医薬品 （LVP）の価格：タイプ別 (2017-2022)
    • 世界の大容量非経口医薬品 （LVP）の価格予測：タイプ別 (2023-2028)

第5章 市場規模：アプリケーション別

  • 世界の大容量非経口医薬品 （LVP）の販売：アプリケーション別
    • 世界の大容量非経口医薬品 （LVP）の販売実績：アプリケーション別 (2017-2022)
    • 世界の大容量非経口医薬品 （LVP）の販売予測：アプリケーション別 (2023-2028)
    • 世界の大容量非経口医薬品 （LVP）の販売市場シェア：アプリケーション別 (2017-2028)
  • 世界の大容量非経口医薬品 （LVP）の収益：アプリケーション別
    • 世界の大容量非経口医薬品 （LVP）の収益実績：アプリケーション別 (2017-2022)
    • 世界の大容量非経口医薬品 （LVP）の収益予測：アプリケーション別 (2023-2028)
    • 世界の大容量非経口医薬品 （LVP）の収益市場シェア：アプリケーション別 (2017-2028)
  • 世界の大容量非経口医薬品 （LVP）の価格：アプリケーション別
    • 世界の大容量非経口医薬品 （LVP）の価格：アプリケーション別 (2017-2022)
    • 世界の大容量非経口医薬品 （LVP）の価格予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の大容量非経口医薬品 （LVP） 市場規模：タイプ別
    • 北米の大容量非経口医薬品 （LVP）の販売：タイプ別 (2017-2028)
    • 北米の大容量非経口医薬品 （LVP）の収益：タイプ別 (2017-2028)
  • 北米の大容量非経口医薬品 （LVP） 市場規模：アプリケーション別
    • 北米の大容量非経口医薬品 （LVP）の販売：アプリケーション別 (2017-2028)
    • 北米の大容量非経口医薬品 （LVP）の収益：アプリケーション別 (2017-2028)
  • 北米の大容量非経口医薬品 （LVP） 市場規模：国別
    • 北米の大容量非経口医薬品 （LVP）の販売：国別 (2017-2028)
    • 北米の大容量非経口医薬品 （LVP）の収益：国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の大容量非経口医薬品 （LVP） 市場規模：タイプ別
    • 欧州の大容量非経口医薬品 （LVP）の販売：タイプ別 (2017-2028)
    • 欧州の大容量非経口医薬品 （LVP）の収益：タイプ別 (2017-2028)
  • 欧州の大容量非経口医薬品 （LVP） 市場規模：アプリケーション別
    • 欧州の大容量非経口医薬品 （LVP）の販売：アプリケーション別 (2017-2028)
    • 欧州の大容量非経口医薬品 （LVP）の収益：アプリケーション別 (2017-2028)
  • 欧州の大容量非経口医薬品 （LVP） 市場規模：国別
    • 欧州の大容量非経口医薬品 （LVP）の販売：国別 (2017-2028)
    • 欧州の大容量非経口医薬品 （LVP）の収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋の大容量非経口医薬品 （LVP） 市場規模：タイプ別
    • アジア太平洋の大容量非経口医薬品 （LVP）の販売：タイプ別 (2017-2028)
    • アジア太平洋の大容量非経口医薬品 （LVP）の収益：タイプ別 (2017-2028)
  • アジア太平洋の大容量非経口医薬品 （LVP） 市場規模：アプリケーション別
    • アジア太平洋の大容量非経口医薬品 （LVP）の販売：アプリケーション別 (2017-2028)
    • アジア太平洋の大容量非経口医薬品 （LVP）の収益：アプリケーション別 (2017-2028)
  • アジア太平洋の大容量非経口医薬品 （LVP） 市場規模：地域別
    • アジア太平洋の大容量非経口医薬品 （LVP）の販売：地域別 (2017-2028)
    • アジア太平洋の大容量非経口医薬品 （LVP）の収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア

第9章 ラテンアメリカ

  • ラテンアメリカの大容量非経口医薬品 （LVP） 市場規模：タイプ別
    • ラテンアメリカの大容量非経口医薬品 （LVP）の販売：タイプ別 (2017-2028)
    • ラテンアメリカの大容量非経口医薬品 （LVP）の収益：タイプ別 (2017-2028)
  • ラテンアメリカの大容量非経口医薬品 （LVP） 市場規模：アプリケーション別
    • ラテンアメリカの大容量非経口医薬品 （LVP）の販売：アプリケーション別 (2017-2028)
    • ラテンアメリカの大容量非経口医薬品 （LVP）の収益：アプリケーション別 (2017-2028)
  • ラテンアメリカの大容量非経口医薬品 （LVP） 市場規模：国別
    • ラテンアメリカの大容量非経口医薬品 （LVP）の販売：国別 (2017-2028)
    • ラテンアメリカの大容量非経口医薬品 （LVP）の収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカの大容量非経口医薬品 （LVP） 市場規模：タイプ別
    • 中東・アフリカの大容量非経口医薬品 （LVP）の販売：タイプ別 (2017-2028)
    • 中東・アフリカの大容量非経口医薬品 （LVP）の収益：タイプ別 (2017-2028)
  • 中東・アフリカの大容量非経口医薬品 （LVP） 市場規模：アプリケーション別
    • 中東・アフリカの大容量非経口医薬品 （LVP）の販売：アプリケーション別 (2017-2028)
    • 中東・アフリカの大容量非経口医薬品 （LVP）の収益：アプリケーション別 (2017-2028)
  • 中東・アフリカの大容量非経口医薬品 （LVP） 市場規模：国別
    • 中東・アフリカの大容量非経口医薬品 （LVP）の販売：国別 (2017-2028)
    • 中東・アフリカの大容量非経口医薬品 （LVP）の収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • Baxter Healthcare
  • Kelun Pharma
  • B. Braun
  • Fresenius
  • Teva Pharmaceutical Industries
  • Pfizer (Hospira)
  • Ostuka Pharmaceutical
  • CR Double-Crane
  • Pisa
  • Huaren
  • Patheon
  • Beximco Pharma
  • Albert David
  • PSI Ltd
  • Ozon Pharmaceuticals
  • BAG Healthcare
  • BML Parenteral Drugs

第12章 業界チェーンと販売チャネルの分析

  • 大容量非経口医薬品 （LVP） 業界チェーン分析
  • 大容量非経口医薬品 （LVP） 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • 大容量非経口医薬品 （LVP） 生産形態とプロセス
  • 大容量非経口医薬品 （LVP） 販売およびマーケティング
    • 大容量非経口医薬品 （LVP） 販売チャネル
    • 大容量非経口医薬品 （LVP） 卸業者
  • 大容量非経口医薬品 （LVP） 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • 大容量非経口医薬品 （LVP） 業界動向
  • 大容量非経口医薬品 （LVP） 市場の促進要因
  • 大容量非経口医薬品 （LVP） 市場の課題
  • 大容量非経口医薬品 （LVP） 市場の抑制要因

第14章 世界の大容量非経口医薬品 （LVP）の主な市場調査結果

第15章 付録

図表
  • Table 1. Global Large Volume Parenteral (LVP) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Soft Bag LVP
  • Table 3. Major Manufacturers of Plastic Bottle LVP
  • Table 4. Major Manufacturers of Glass Bottle LVP
  • Table 5. Global Large Volume Parenteral (LVP) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Large Volume Parenteral (LVP) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 7. Global Large Volume Parenteral (LVP) Sales by Region (2017-2022) & (M Units)
  • Table 8. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2017-2022)
  • Table 9. Global Large Volume Parenteral (LVP) Sales by Region (2023-2028) & (M Units)
  • Table 10. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2023-2028)
  • Table 11. Global Large Volume Parenteral (LVP) Revenue by Region (2017-2022) & (US$ Million)
  • Table 12. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2017-2022)
  • Table 13. Global Large Volume Parenteral (LVP) Revenue by Region (2023-2028) & (US$ Million)
  • Table 14. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2023-2028)
  • Table 15. Global Large Volume Parenteral (LVP) Sales by Manufacturers (2017-2022) & (M Units)
  • Table 16. Global Large Volume Parenteral (LVP) Sales Share by Manufacturers (2017-2022)
  • Table 17. Global Large Volume Parenteral (LVP) Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 18. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2017-2022)
  • Table 19. Large Volume Parenteral (LVP) Price by Manufacturers (2017-2022) &(US$/K Units)
  • Table 20. Global Large Volume Parenteral (LVP) Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 21. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Large Volume Parenteral (LVP) as of 2021)
  • Table 22. Large Volume Parenteral (LVP) Manufacturing Base Distribution and Headquarters
  • Table 23. Manufacturers Large Volume Parenteral (LVP) Product Offered
  • Table 24. Date of Manufacturers Enter into Large Volume Parenteral (LVP) Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Large Volume Parenteral (LVP) Sales by Type (2017-2022) & (M Units)
  • Table 27. Global Large Volume Parenteral (LVP) Sales by Type (2023-2028) & (M Units)
  • Table 28. Global Large Volume Parenteral (LVP) Sales Share by Type (2017-2022)
  • Table 29. Global Large Volume Parenteral (LVP) Sales Share by Type (2023-2028)
  • Table 30. Global Large Volume Parenteral (LVP) Revenue by Type (2017-2022) & (US$ Million)
  • Table 31. Global Large Volume Parenteral (LVP) Revenue by Type (2023-2028) & (US$ Million)
  • Table 32. Global Large Volume Parenteral (LVP) Revenue Share by Type (2017-2022)
  • Table 33. Global Large Volume Parenteral (LVP) Revenue Share by Type (2023-2028)
  • Table 34. Large Volume Parenteral (LVP) Price by Type (2017-2022) & (US$/K Units)
  • Table 35. Global Large Volume Parenteral (LVP) Price Forecast by Type (2023-2028) & (US$/K Units)
  • Table 36. Global Large Volume Parenteral (LVP) Sales by Application (2017-2022) & (M Units)
  • Table 37. Global Large Volume Parenteral (LVP) Sales by Application (2023-2028) & (M Units)
  • Table 38. Global Large Volume Parenteral (LVP) Sales Share by Application (2017-2022)
  • Table 39. Global Large Volume Parenteral (LVP) Sales Share by Application (2023-2028)
  • Table 40. Global Large Volume Parenteral (LVP) Revenue by Application (2017-2022) & (US$ Million)
  • Table 41. Global Large Volume Parenteral (LVP) Revenue by Application (2023-2028) & (US$ Million)
  • Table 42. Global Large Volume Parenteral (LVP) Revenue Share by Application (2017-2022)
  • Table 43. Global Large Volume Parenteral (LVP) Revenue Share by Application (2023-2028)
  • Table 44. Large Volume Parenteral (LVP) Price by Application (2017-2022) & (US$/K Units)
  • Table 45. Global Large Volume Parenteral (LVP) Price Forecast by Application (2023-2028) & (US$/K Units)
  • Table 46. North America Large Volume Parenteral (LVP) Sales by Type (2017-2022) & (M Units)
  • Table 47. North America Large Volume Parenteral (LVP) Sales by Type (2023-2028) & (M Units)
  • Table 48. North America Large Volume Parenteral (LVP) Revenue by Type (2017-2022) & (US$ Million)
  • Table 49. North America Large Volume Parenteral (LVP) Revenue by Type (2023-2028) & (US$ Million)
  • Table 50. North America Large Volume Parenteral (LVP) Sales by Application (2017-2022) & (M Units)
  • Table 51. North America Large Volume Parenteral (LVP) Sales by Application (2023-2028) & (M Units)
  • Table 52. North America Large Volume Parenteral (LVP) Revenue by Application (2017-2022) & (US$ Million)
  • Table 53. North America Large Volume Parenteral (LVP) Revenue by Application (2023-2028) & (US$ Million)
  • Table 54. North America Large Volume Parenteral (LVP) Sales by Country (2017-2022) & (M Units)
  • Table 55. North America Large Volume Parenteral (LVP) Sales by Country (2023-2028) & (M Units)
  • Table 56. North America Large Volume Parenteral (LVP) Revenue by Country (2017-2022) & (US$ Million)
  • Table 57. North America Large Volume Parenteral (LVP) Revenue by Country (2023-2028) & (US$ Million)
  • Table 58. Europe Large Volume Parenteral (LVP) Sales by Type (2017-2022) & (M Units)
  • Table 59. Europe Large Volume Parenteral (LVP) Sales by Type (2023-2028) & (M Units)
  • Table 60. Europe Large Volume Parenteral (LVP) Revenue by Type (2017-2022) & (US$ Million)
  • Table 61. Europe Large Volume Parenteral (LVP) Revenue by Type (2023-2028) & (US$ Million)
  • Table 62. Europe Large Volume Parenteral (LVP) Sales by Application (2017-2022) & (M Units)
  • Table 63. Europe Large Volume Parenteral (LVP) Sales by Application (2023-2028) & (M Units)
  • Table 64. Europe Large Volume Parenteral (LVP) Revenue by Application (2017-2022) & (US$ Million)
  • Table 65. Europe Large Volume Parenteral (LVP) Revenue by Application (2023-2028) & (US$ Million)
  • Table 66. Europe Large Volume Parenteral (LVP) Sales by Country (2017-2022) & (M Units)
  • Table 67. Europe Large Volume Parenteral (LVP) Sales by Country (2023-2028) & (M Units)
  • Table 68. Europe Large Volume Parenteral (LVP) Revenue by Country (2017-2022) & (US$ Million)
  • Table 69. Europe Large Volume Parenteral (LVP) Revenue by Country (2023-2028) & (US$ Million)
  • Table 70. Asia Pacific Large Volume Parenteral (LVP) Sales by Type (2017-2022) & (M Units)
  • Table 71. Asia Pacific Large Volume Parenteral (LVP) Sales by Type (2023-2028) & (M Units)
  • Table 72. Asia Pacific Large Volume Parenteral (LVP) Revenue by Type (2017-2022) & (US$ Million)
  • Table 73. Asia Pacific Large Volume Parenteral (LVP) Revenue by Type (2023-2028) & (US$ Million)
  • Table 74. Asia Pacific Large Volume Parenteral (LVP) Sales by Application (2017-2022) & (M Units)
  • Table 75. Asia Pacific Large Volume Parenteral (LVP) Sales by Application (2023-2028) & (M Units)
  • Table 76. Asia Pacific Large Volume Parenteral (LVP) Revenue by Application (2017-2022) & (US$ Million)
  • Table 77. Asia Pacific Large Volume Parenteral (LVP) Revenue by Application (2023-2028) & (US$ Million)
  • Table 78. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2017-2022) & (M Units)
  • Table 79. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2023-2028) & (M Units)
  • Table 80. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2017-2022) & (US$ Million)
  • Table 81. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2023-2028) & (US$ Million)
  • Table 82. Latin America Large Volume Parenteral (LVP) Sales by Type (2017-2022) & (M Units)
  • Table 83. Latin America Large Volume Parenteral (LVP) Sales by Type (2023-2028) & (M Units)
  • Table 84. Latin America Large Volume Parenteral (LVP) Revenue by Type (2017-2022) & (US$ Million)
  • Table 85. Latin America Large Volume Parenteral (LVP) Revenue by Type (2023-2028) & (US$ Million)
  • Table 86. Latin America Large Volume Parenteral (LVP) Sales by Application (2017-2022) & (M Units)
  • Table 87. Latin America Large Volume Parenteral (LVP) Sales by Application (2023-2028) & (M Units)
  • Table 88. Latin America Large Volume Parenteral (LVP) Revenue by Application (2017-2022) & (US$ Million)
  • Table 89. Latin America Large Volume Parenteral (LVP) Revenue by Application (2023-2028) & (US$ Million)
  • Table 90. Latin America Large Volume Parenteral (LVP) Sales by Country (2017-2022) & (M Units)
  • Table 91. Latin America Large Volume Parenteral (LVP) Sales by Country (2023-2028) & (M Units)
  • Table 92. Latin America Large Volume Parenteral (LVP) Revenue by Country (2017-2022) & (US$ Million)
  • Table 93. Latin America Large Volume Parenteral (LVP) Revenue by Country (2023-2028) & (US$ Million)
  • Table 94. Middle East and Africa Large Volume Parenteral (LVP) Sales by Type (2017-2022) & (M Units)
  • Table 95. Middle East and Africa Large Volume Parenteral (LVP) Sales by Type (2023-2028) & (M Units)
  • Table 96. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Type (2017-2022) & (US$ Million)
  • Table 97. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Type (2023-2028) & (US$ Million)
  • Table 98. Middle East and Africa Large Volume Parenteral (LVP) Sales by Application (2017-2022) & (M Units)
  • Table 99. Middle East and Africa Large Volume Parenteral (LVP) Sales by Application (2023-2028) & (M Units)
  • Table 100. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Application (2017-2022) & (US$ Million)
  • Table 101. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Application (2023-2028) & (US$ Million)
  • Table 102. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2017-2022) & (M Units)
  • Table 103. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2023-2028) & (M Units)
  • Table 104. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2017-2022) & (US$ Million)
  • Table 105. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2023-2028) & (US$ Million)
  • Table 106. Baxter Healthcare Corporation Information
  • Table 107. Baxter Healthcare Description and Major Businesses
  • Table 108. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 109. Baxter Healthcare Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 110. Baxter Healthcare Recent Developments
  • Table 111. Kelun Pharma Corporation Information
  • Table 112. Kelun Pharma Description and Major Businesses
  • Table 113. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 114. Kelun Pharma Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. Kelun Pharma Recent Developments
  • Table 116. B. Braun Corporation Information
  • Table 117. B. Braun Description and Major Businesses
  • Table 118. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 119. B. Braun Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. B. Braun Recent Developments
  • Table 121. Fresenius Corporation Information
  • Table 122. Fresenius Description and Major Businesses
  • Table 123. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 124. Fresenius Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. Fresenius Recent Developments
  • Table 126. Teva Pharmaceutical Industries Corporation Information
  • Table 127. Teva Pharmaceutical Industries Description and Major Businesses
  • Table 128. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 129. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. Teva Pharmaceutical Industries Recent Developments
  • Table 131. Pfizer (Hospira) Corporation Information
  • Table 132. Pfizer (Hospira) Description and Major Businesses
  • Table 133. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 134. Pfizer (Hospira) Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. Pfizer (Hospira) Recent Developments
  • Table 136. Ostuka Pharmaceutical Corporation Information
  • Table 137. Ostuka Pharmaceutical Description and Major Businesses
  • Table 138. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 139. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 140. Ostuka Pharmaceutical Recent Developments
  • Table 141. CR Double-Crane Corporation Information
  • Table 142. CR Double-Crane Description and Major Businesses
  • Table 143. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 144. CR Double-Crane Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 145. CR Double-Crane Recent Developments
  • Table 146. Pisa Corporation Information
  • Table 147. Pisa Description and Major Businesses
  • Table 148. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 149. Pisa Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 150. Pisa Recent Developments
  • Table 151. Huaren Corporation Information
  • Table 152. Huaren Description and Major Businesses
  • Table 153. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 154. Huaren Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 155. Huaren Recent Developments
  • Table 156. Patheon Corporation Information
  • Table 157. Patheon Description and Major Businesses
  • Table 158. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 159. Patheon Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 160. Patheon Recent Developments
  • Table 161. Beximco Pharma Corporation Information
  • Table 162. Beximco Pharma Description and Major Businesses
  • Table 163. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 164. Beximco Pharma Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 165. Beximco Pharma Recent Developments
  • Table 166. Albert David Corporation Information
  • Table 167. Albert David Description and Major Businesses
  • Table 168. Albert David Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 169. Albert David Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 170. Albert David Recent Developments
  • Table 171. PSI Ltd Corporation Information
  • Table 172. PSI Ltd Description and Major Businesses
  • Table 173. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 174. PSI Ltd Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 175. PSI Ltd Recent Developments
  • Table 176. Ozon Pharmaceuticals Corporation Information
  • Table 177. Ozon Pharmaceuticals Description and Major Businesses
  • Table 178. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 179. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 180. Ozon Pharmaceuticals Recent Developments
  • Table 181. BAG Healthcare Corporation Information
  • Table 182. BAG Healthcare Description and Major Businesses
  • Table 183. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 184. BAG Healthcare Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 185. BAG Healthcare Recent Developments
  • Table 186. BML Parenteral Drugs Corporation Information
  • Table 187. BML Parenteral Drugs Description and Major Businesses
  • Table 188. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
  • Table 189. BML Parenteral Drugs Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 190. BML Parenteral Drugs Recent Developments
  • Table 191. Key Raw Materials Lists
  • Table 192. Raw Materials Key Suppliers Lists
  • Table 193. Large Volume Parenteral (LVP) Distributors List
  • Table 194. Large Volume Parenteral (LVP) Customers List
  • Table 195. Large Volume Parenteral (LVP) Market Trends
  • Table 196. Large Volume Parenteral (LVP) Market Drivers
  • Table 197. Large Volume Parenteral (LVP) Market Challenges
  • Table 198. Large Volume Parenteral (LVP) Market Restraints
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Large Volume Parenteral (LVP) Product Picture
  • Figure 3. Global Large Volume Parenteral (LVP) Market Share by Type in 2021 & 2028
  • Figure 3. Soft Bag LVP Product Picture
  • Figure 4. Plastic Bottle LVP Product Picture
  • Figure 5. Glass Bottle LVP Product Picture
  • Figure 6. Global Large Volume Parenteral (LVP) Market Share by Application in 2021 & 2028
  • Figure 7. Basic Infusion
  • Figure 8. Therapeutic Infusion
  • Figure 9. Nutritious Infusion
  • Figure 10. Large Volume Parenteral (LVP) Report Years Considered
  • Figure 11. Global Large Volume Parenteral (LVP) Sales 2017-2028 (M Units)
  • Figure 12. Global Large Volume Parenteral (LVP) Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Large Volume Parenteral (LVP) Revenue 2017-2028 (US$ Million)
  • Figure 14. Global Large Volume Parenteral (LVP) Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 15. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2017-2022)
  • Figure 16. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2023-2028)
  • Figure 17. North America Large Volume Parenteral (LVP) Sales YoY (2017-2028) & (M Units)
  • Figure 18. North America Large Volume Parenteral (LVP) Revenue YoY (2017-2028) & (US$ Million)
  • Figure 19. Europe Large Volume Parenteral (LVP) Sales YoY (2017-2028) & (M Units)
  • Figure 20. Europe Large Volume Parenteral (LVP) Revenue YoY (2017-2028) & (US$ Million)
  • Figure 21. Asia-Pacific Large Volume Parenteral (LVP) Sales YoY (2017-2028) & (M Units)
  • Figure 22. Asia-Pacific Large Volume Parenteral (LVP) Revenue YoY (2017-2028) & (US$ Million)
  • Figure 23. Latin America Large Volume Parenteral (LVP) Sales YoY (2017-2028) & (M Units)
  • Figure 24. Latin America Large Volume Parenteral (LVP) Revenue YoY (2017-2028) & (US$ Million)
  • Figure 25. Middle East & Africa Large Volume Parenteral (LVP) Sales YoY (2017-2028) & (M Units)
  • Figure 26. Middle East & Africa Large Volume Parenteral (LVP) Revenue YoY (2017-2028) & (US$ Million)
  • Figure 27. The Large Volume Parenteral (LVP) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 28. The Top 5 and 10 Largest Manufacturers of Large Volume Parenteral (LVP) in the World: Market Share by Large Volume Parenteral (LVP) Revenue in 2021
  • Figure 29. Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 30. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2017-2028)
  • Figure 31. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2017-2028)
  • Figure 32. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2017-2028)
  • Figure 33. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2017-2028)
  • Figure 34. North America Large Volume Parenteral (LVP) Sales Market Share by Type (2017-2028)
  • Figure 35. North America Large Volume Parenteral (LVP) Revenue Market Share by Type (2017-2028)
  • Figure 36. North America Large Volume Parenteral (LVP) Sales Market Share by Application (2017-2028)
  • Figure 37. North America Large Volume Parenteral (LVP) Revenue Market Share by Application (2017-2028)
  • Figure 38. North America Large Volume Parenteral (LVP) Sales Share by Country (2017-2028)
  • Figure 39. North America Large Volume Parenteral (LVP) Revenue Share by Country (2017-2028)
  • Figure 40. U.S. Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 41. Canada Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 42. Europe Large Volume Parenteral (LVP) Sales Market Share by Type (2017-2028)
  • Figure 43. Europe Large Volume Parenteral (LVP) Revenue Market Share by Type (2017-2028)
  • Figure 44. Europe Large Volume Parenteral (LVP) Sales Market Share by Application (2017-2028)
  • Figure 45. Europe Large Volume Parenteral (LVP) Revenue Market Share by Application (2017-2028)
  • Figure 46. Europe Large Volume Parenteral (LVP) Sales Share by Country (2017-2028)
  • Figure 47. Europe Large Volume Parenteral (LVP) Revenue Share by Country (2017-2028)
  • Figure 48. Germany Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 49. France Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 50. U.K. Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 51. Italy Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 52. Russia Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 53. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Type (2017-2028)
  • Figure 54. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Type (2017-2028)
  • Figure 55. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Application (2017-2028)
  • Figure 56. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Application (2017-2028)
  • Figure 57. Asia Pacific Large Volume Parenteral (LVP) Sales Share by Region (2017-2028)
  • Figure 58. Asia Pacific Large Volume Parenteral (LVP) Revenue Share by Region (2017-2028)
  • Figure 59. China Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 60. Japan Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 61. South Korea Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 62. India Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 63. Australia Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 64. China Taiwan Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 65. Indonesia Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 66. Thailand Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 67. Malaysia Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 68. Latin America Large Volume Parenteral (LVP) Sales Market Share by Type (2017-2028)
  • Figure 69. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Type (2017-2028)
  • Figure 70. Latin America Large Volume Parenteral (LVP) Sales Market Share by Application (2017-2028)
  • Figure 71. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Application (2017-2028)
  • Figure 72. Latin America Large Volume Parenteral (LVP) Sales Share by Country (2017-2028)
  • Figure 73. Latin America Large Volume Parenteral (LVP) Revenue Share by Country (2017-2028)
  • Figure 74. Mexico Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 75. Brazil Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 76. Argentina Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 77. Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Type (2017-2028)
  • Figure 78. Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Type (2017-2028)
  • Figure 79. Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Application (2017-2028)
  • Figure 80. Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Application (2017-2028)
  • Figure 81. Middle East and Africa Large Volume Parenteral (LVP) Sales Share by Country (2017-2028)
  • Figure 82. Middle East and Africa Large Volume Parenteral (LVP) Revenue Share by Country (2017-2028)
  • Figure 83. Turkey Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 84. Saudi Arabia Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 85. UAE Large Volume Parenteral (LVP) Revenue (2017-2028) & (US$ Million)
  • Figure 86. Large Volume Parenteral (LVP) Value Chain
  • Figure 87. Large Volume Parenteral (LVP) Production Process
  • Figure 88. Channels of Distribution
  • Figure 89. Distributors Profiles
  • Figure 90. Bottom-up and Top-down Approaches for This Report
  • Figure 91. Data Triangulation
  • Figure 92. Key Executives Interviewed
目次

This research report focuses on the Large Volume Parenteral (LVP) Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Large Volume Parenteral (LVP) Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Large Volume Parenteral (LVP) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Soft Bag LVP
    • 1.2.3 Plastic Bottle LVP
    • 1.2.4 Glass Bottle LVP
  • 1.3 Market by Application
    • 1.3.1 Global Large Volume Parenteral (LVP) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Basic Infusion
    • 1.3.3 Therapeutic Infusion
    • 1.3.4 Nutritious Infusion
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Large Volume Parenteral (LVP) Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Large Volume Parenteral (LVP) Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Large Volume Parenteral (LVP) Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Large Volume Parenteral (LVP) Sales by Region
    • 2.4.1 Global Large Volume Parenteral (LVP) Sales by Region (2017-2022)
    • 2.4.2 Global Sales Large Volume Parenteral (LVP) by Region (2023-2028)
  • 2.5 Global Large Volume Parenteral (LVP) Revenue by Region
    • 2.5.1 Global Large Volume Parenteral (LVP) Revenue by Region (2017-2022)
    • 2.5.2 Global Large Volume Parenteral (LVP) Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Large Volume Parenteral (LVP) Sales by Manufacturers
    • 3.1.1 Global Top Large Volume Parenteral (LVP) Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Large Volume Parenteral (LVP) in 2021
  • 3.2 Global Large Volume Parenteral (LVP) Revenue by Manufacturers
    • 3.2.1 Global Large Volume Parenteral (LVP) Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Large Volume Parenteral (LVP) Revenue in 2021
  • 3.3 Global Large Volume Parenteral (LVP) Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Large Volume Parenteral (LVP) Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Large Volume Parenteral (LVP) Sales by Type
    • 4.1.1 Global Large Volume Parenteral (LVP) Historical Sales by Type (2017-2022)
    • 4.1.2 Global Large Volume Parenteral (LVP) Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2017-2028)
  • 4.2 Global Large Volume Parenteral (LVP) Revenue by Type
    • 4.2.1 Global Large Volume Parenteral (LVP) Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Large Volume Parenteral (LVP) Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2017-2028)
  • 4.3 Global Large Volume Parenteral (LVP) Price by Type
    • 4.3.1 Global Large Volume Parenteral (LVP) Price by Type (2017-2022)
    • 4.3.2 Global Large Volume Parenteral (LVP) Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Large Volume Parenteral (LVP) Sales by Application
    • 5.1.1 Global Large Volume Parenteral (LVP) Historical Sales by Application (2017-2022)
    • 5.1.2 Global Large Volume Parenteral (LVP) Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2017-2028)
  • 5.2 Global Large Volume Parenteral (LVP) Revenue by Application
    • 5.2.1 Global Large Volume Parenteral (LVP) Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Large Volume Parenteral (LVP) Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2017-2028)
  • 5.3 Global Large Volume Parenteral (LVP) Price by Application
    • 5.3.1 Global Large Volume Parenteral (LVP) Price by Application (2017-2022)
    • 5.3.2 Global Large Volume Parenteral (LVP) Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Large Volume Parenteral (LVP) Market Size by Type
    • 6.1.1 North America Large Volume Parenteral (LVP) Sales by Type (2017-2028)
    • 6.1.2 North America Large Volume Parenteral (LVP) Revenue by Type (2017-2028)
  • 6.2 North America Large Volume Parenteral (LVP) Market Size by Application
    • 6.2.1 North America Large Volume Parenteral (LVP) Sales by Application (2017-2028)
    • 6.2.2 North America Large Volume Parenteral (LVP) Revenue by Application (2017-2028)
  • 6.3 North America Large Volume Parenteral (LVP) Market Size by Country
    • 6.3.1 North America Large Volume Parenteral (LVP) Sales by Country (2017-2028)
    • 6.3.2 North America Large Volume Parenteral (LVP) Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Large Volume Parenteral (LVP) Market Size by Type
    • 7.1.1 Europe Large Volume Parenteral (LVP) Sales by Type (2017-2028)
    • 7.1.2 Europe Large Volume Parenteral (LVP) Revenue by Type (2017-2028)
  • 7.2 Europe Large Volume Parenteral (LVP) Market Size by Application
    • 7.2.1 Europe Large Volume Parenteral (LVP) Sales by Application (2017-2028)
    • 7.2.2 Europe Large Volume Parenteral (LVP) Revenue by Application (2017-2028)
  • 7.3 Europe Large Volume Parenteral (LVP) Market Size by Country
    • 7.3.1 Europe Large Volume Parenteral (LVP) Sales by Country (2017-2028)
    • 7.3.2 Europe Large Volume Parenteral (LVP) Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Large Volume Parenteral (LVP) Market Size by Type
    • 8.1.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Large Volume Parenteral (LVP) Market Size by Application
    • 8.2.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Large Volume Parenteral (LVP) Market Size by Region
    • 8.3.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 China Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia

9 Latin America

  • 9.1 Latin America Large Volume Parenteral (LVP) Market Size by Type
    • 9.1.1 Latin America Large Volume Parenteral (LVP) Sales by Type (2017-2028)
    • 9.1.2 Latin America Large Volume Parenteral (LVP) Revenue by Type (2017-2028)
  • 9.2 Latin America Large Volume Parenteral (LVP) Market Size by Application
    • 9.2.1 Latin America Large Volume Parenteral (LVP) Sales by Application (2017-2028)
    • 9.2.2 Latin America Large Volume Parenteral (LVP) Revenue by Application (2017-2028)
  • 9.3 Latin America Large Volume Parenteral (LVP) Market Size by Country
    • 9.3.1 Latin America Large Volume Parenteral (LVP) Sales by Country (2017-2028)
    • 9.3.2 Latin America Large Volume Parenteral (LVP) Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Type
    • 10.1.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Application
    • 10.2.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Country
    • 10.3.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Baxter Healthcare
    • 11.1.1 Baxter Healthcare Corporation Information
    • 11.1.2 Baxter Healthcare Overview
    • 11.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Baxter Healthcare Recent Developments
  • 11.2 Kelun Pharma
    • 11.2.1 Kelun Pharma Corporation Information
    • 11.2.2 Kelun Pharma Overview
    • 11.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Kelun Pharma Recent Developments
  • 11.3 B. Braun
    • 11.3.1 B. Braun Corporation Information
    • 11.3.2 B. Braun Overview
    • 11.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 B. Braun Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 B. Braun Recent Developments
  • 11.4 Fresenius
    • 11.4.1 Fresenius Corporation Information
    • 11.4.2 Fresenius Overview
    • 11.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Fresenius Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Fresenius Recent Developments
  • 11.5 Teva Pharmaceutical Industries
    • 11.5.1 Teva Pharmaceutical Industries Corporation Information
    • 11.5.2 Teva Pharmaceutical Industries Overview
    • 11.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Teva Pharmaceutical Industries Recent Developments
  • 11.6 Pfizer (Hospira)
    • 11.6.1 Pfizer (Hospira) Corporation Information
    • 11.6.2 Pfizer (Hospira) Overview
    • 11.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Pfizer (Hospira) Recent Developments
  • 11.7 Ostuka Pharmaceutical
    • 11.7.1 Ostuka Pharmaceutical Corporation Information
    • 11.7.2 Ostuka Pharmaceutical Overview
    • 11.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Ostuka Pharmaceutical Recent Developments
  • 11.8 CR Double-Crane
    • 11.8.1 CR Double-Crane Corporation Information
    • 11.8.2 CR Double-Crane Overview
    • 11.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 CR Double-Crane Recent Developments
  • 11.9 Pisa
    • 11.9.1 Pisa Corporation Information
    • 11.9.2 Pisa Overview
    • 11.9.3 Pisa Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Pisa Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Pisa Recent Developments
  • 11.10 Huaren
    • 11.10.1 Huaren Corporation Information
    • 11.10.2 Huaren Overview
    • 11.10.3 Huaren Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 Huaren Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Huaren Recent Developments
  • 11.11 Patheon
    • 11.11.1 Patheon Corporation Information
    • 11.11.2 Patheon Overview
    • 11.11.3 Patheon Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.11.4 Patheon Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Patheon Recent Developments
  • 11.12 Beximco Pharma
    • 11.12.1 Beximco Pharma Corporation Information
    • 11.12.2 Beximco Pharma Overview
    • 11.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Beximco Pharma Recent Developments
  • 11.13 Albert David
    • 11.13.1 Albert David Corporation Information
    • 11.13.2 Albert David Overview
    • 11.13.3 Albert David Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.13.4 Albert David Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Albert David Recent Developments
  • 11.14 PSI Ltd
    • 11.14.1 PSI Ltd Corporation Information
    • 11.14.2 PSI Ltd Overview
    • 11.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 PSI Ltd Recent Developments
  • 11.15 Ozon Pharmaceuticals
    • 11.15.1 Ozon Pharmaceuticals Corporation Information
    • 11.15.2 Ozon Pharmaceuticals Overview
    • 11.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Ozon Pharmaceuticals Recent Developments
  • 11.16 BAG Healthcare
    • 11.16.1 BAG Healthcare Corporation Information
    • 11.16.2 BAG Healthcare Overview
    • 11.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.16.5 BAG Healthcare Recent Developments
  • 11.17 BML Parenteral Drugs
    • 11.17.1 BML Parenteral Drugs Corporation Information
    • 11.17.2 BML Parenteral Drugs Overview
    • 11.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.17.5 BML Parenteral Drugs Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Large Volume Parenteral (LVP) Industry Chain Analysis
  • 12.2 Large Volume Parenteral (LVP) Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Large Volume Parenteral (LVP) Production Mode & Process
  • 12.4 Large Volume Parenteral (LVP) Sales and Marketing
    • 12.4.1 Large Volume Parenteral (LVP) Sales Channels
    • 12.4.2 Large Volume Parenteral (LVP) Distributors
  • 12.5 Large Volume Parenteral (LVP) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Large Volume Parenteral (LVP) Industry Trends
  • 13.2 Large Volume Parenteral (LVP) Market Drivers
  • 13.3 Large Volume Parenteral (LVP) Market Challenges
  • 13.4 Large Volume Parenteral (LVP) Market Restraints

14 Key Findings in The Global Large Volume Parenteral (LVP) Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer